A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis
Sponsor: Novartis Pharmaceuticals
Chicago, IL · +42 more sites
23 recruiting multiple sclerosis studies with a site in Chicago, IL.
Sponsor: Novartis Pharmaceuticals
Chicago, IL · +42 more sites
Sponsor: University of Illinois at Chicago
Chicago, IL
Sponsor: National Cancer Institute (NCI)
Chicago, IL · +49 more sites
Sponsor: Darcy Krueger
Chicago, IL · +10 more sites
Sponsor: TG Therapeutics, Inc.
Chicago, IL · Evanston, IL · +106 more sites
Sponsor: TG Therapeutics, Inc.
Chicago, IL · +40 more sites
Sponsor: Reunion Neuroscience Inc
Chicago, IL · +30 more sites
Sponsor: Bristol-Myers Squibb
Chicago, IL · +10 more sites
Sponsor: Shirley Ryan AbilityLab
Chicago, IL
Sponsor: Novartis Pharmaceuticals
Chicago, IL · +42 more sites
Sponsor: AstraZeneca
Chicago, IL · +7 more sites
Sponsor: Northwestern University
Chicago, IL
Sponsor: University of Illinois at Chicago
Chicago, IL
Sponsor: University of Illinois at Chicago
Chicago, IL
Sponsor: National Tuberous Sclerosis Association
Chicago, IL · +23 more sites
Sponsor: University of Illinois at Chicago
Chicago, IL
Sponsor: Shirley Ryan AbilityLab
Chicago, IL
Sponsor: Shirley Ryan AbilityLab
Chicago, IL
Sponsor: Northwestern University
Chicago, IL
Sponsor: Northwestern University
Chicago, IL
Sponsor: Shirley Ryan AbilityLab
Chicago, IL
Sponsor: University of Illinois at Chicago
Chicago, IL
Sponsor: University of Illinois at Chicago
Chicago, IL
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.